About Kinexum


Kinexum was founded a decade ago to support efficient translational research to accelerate and advance healthcare product innovation.   Providing multidisciplinary expertise for management and execution of early stage development programs, Kinexum is a proven leader in virtual translational development strategy and program management to advance innovative healthcare products toward commercialization.

Kinexum has been a leader in the underlying issues, complications, and unmet needs of metabolic diseases including diabetes, obesity, metabolic syndrome, cardiometabolic, inflammation, immune modulation, oncology, retinopathy, neuropathy, and more.


Executive Chairman Dr. Zan Fleming

As an FDA leader for over a decade, Kinexum Executive Chairman Zan Fleming led efforts to re-engineer the organization, shape regulatory policy, and improve the morale and capability of the professional staff.  Read more ...

Leadership and Clients

Learn more about Kinexum's Leadership

Get information about our Clients